Wenming Wu

Title: The Innovations of Wenming Wu

Introduction

Wenming Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of antibody drugs, particularly with his innovative work on anti-CD47 antibodies. His research focuses on developing pharmaceutical compositions that exhibit remarkable antitumor activity.

Latest Patents

Wenming Wu holds a patent for an anti-CD47 antibody and its applications. This patent, which is pivotal in the technical field of antibody drugs, describes an anti-CD47 antibody or an antigen-binding fragment thereof. The invention emphasizes the antibody's high affinity for the human CD47 protein and its ability to eliminate the binding capability of SIRPa to CD47 on cell surfaces. Notably, this antibody does not exhibit significant hemoagglutination activity, making it a promising candidate for anti-tumor drug development. He has 1 patent to his name.

Career Highlights

Wenming Wu is associated with Nanjing Sanhome Pharmaceutical Co., Ltd., where he continues to advance his research in antibody therapies. His work is instrumental in the ongoing development of innovative treatments for cancer.

Collaborations

Wenming Wu collaborates with esteemed colleagues, including Yong Wang and Liwen Zhao, to further enhance the impact of his research in the pharmaceutical industry.

Conclusion

Wenming Wu's contributions to the field of antibody drugs, particularly through his patent on anti-CD47 antibodies, highlight his role as an influential inventor. His work promises to pave the way for new therapeutic options in cancer treatment.